Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor,
As you may be aware, NICPLD recently asked contractors who had previously expressed an interest in participating in the Experiential Learning (EL) programme to confirm their participation and provide an indication of the weeks during which they would be able to facilitate a student.
NICPLD have informed CPNI that sufficient numbers of community pharmacies have now confirmed their participation, meaning that the EL programme will commence as planned in November 2023. NICPLD are now contacting those pharmacists who have been nominated to act as Practice Supervisors for EL to make them aware of the training requirements.
SUMMARY
Key Aspects – Experiential Learning in Community Pharmacy:
The Autumn/Winter 2023 EL programme for community pharmacies will involve the placement of all 3rd year (QUB and UU) pharmacy students in participating community pharmacy training sites.
The initial block of week-long placements in community pharmacies will run from 6th November to 24th November, with further blocks in January 2024.
Participating pharmacies were asked to indicate the weeks during which they can facilitate a student.
Each participating pharmacy was asked to nominate at least one pharmacist to act as a Practice Supervisor for their EL student(s).
Each student will be placed in a pharmacy for a week (Monday – Friday), during which time they will be required to undertake and complete up to 5 defined learning activities, with the support of their Practice Supervisor.
Funding of £592 will be provided to participating community pharmacy contractors for each one-week placement they facilitate.
Training:
NICPLD have advised CPNI that they are now contacting those pharmacists who have been nominated to act as a Practice Supervisor (PS), to inform them of the training and accreditation requirements.
There are 3 elements to PS training and accreditation that nominated pharmacists are required to complete.
2 x NICPLD E-learning Modules on Developing Others which are available on the e-learning area of the NICPLD website:
Effective Workplace Training
Effective Mentoring
Evening Webinar – Practice Supervisors are required to register to attend one evening webinar date in August.
Face to Face Evening Workshop – Practice Supervisors are required to register to attend one evening workshop in September.
Pharmacists who have already completed the E-learning modules on Developing Others within 2 years prior to commencing their role as a PS, will not be required to complete them again, although they may wish to do so as a refresher. For all other pharmacists, both modules must be completed before the start date of the first EL student placement.
Funding has been made available to recognise the time requirement for those pharmacists training as a PS for the initial 2023 programme. The PS will receive a payment of 3 days at £150/day (gross payment), which will be paid to the pharmacy contractor and should be processed accordingly.
ACTION
Contractors who have committed to participating in Experiential Learning in 2023 should take note of the training and accreditation requirements for nominated Practice Supervisors and, where appropriate, share the information in this contractor update with relevant members of the pharmacy team.
Contractors who were previously unable to commit to participating in the EL programme due to workforce and workload pressures will not be excluded from participating in the programme in the future. NICPLD Lead Helen Hirst can be contacted if any contractor requires additional information on providing EL placements going forward.
Should you have any queries please do not hesitate to contact a member of the CPNI team.
Kind regards,
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor,
SUMMARY
SPPG is seeking your opening intentions to ascertain whether or not there is sufficient commercial opening to inform any decision about initiation or otherwise of a rota on Monday 28th August 2023.
The pro-forma was due to be returned to your local Primary Care Office before Monday 24th July 2023.
SPPG have advised that a large number have not yet been submitted. It is important that you submit a return to SPPG in order that it can inform those community pharmacies who are on rota, so they can in turn confirm arrangements with staff.
ACTION
CPNI would encourage pharmacies who have not yet submitted the pro-forma to do so at your earliest convenience to enable planning for the August bank holiday rota.
Should you have any queries please contact CPNI offices or your local SPPG advisor.
Kind regards,
SENT ON BEHALF OF Gerard Greene Chief Executive
— New Data Quality Dashboard on your VMS —
Dear Contractor,
For the attention of Community Pharmacies intending to provide the 2023 Community Pharmacy Vaccine Service (CPVS)
SUMMARY
The PHA have rolled out a new Data Quality Dashboard on VMS. This provides information where records may be missing or where data errors may have occurred. The dashboard can be accessed from the VMS homepage under the ‘Reports and Dashboards’ link.
Vaccines Potentially Missing from VMS Then 1st data quality report is for ‘missing vaccines’. This is where a person has provided evidence of a vaccination to the COVID-19 Vaccine Certification team and been issued a COIVD-19 certificate, but it is not recorded on VMS. See Data Quality Handbook.
ACTION
Pharmacies are asked to check their ‘missing vaccine’ data quality report and record the vaccination on VMS if the information the patient provided to the Certification Team is accurate. Please use the ‘Record previously administered vaccination’ at this location option to record missing vaccinations. Using any other option may mean that the relevant vaccine is not available for recording.
If you have any queries about the Data Quality Dashboard or the information contained in the DQ reports please contact Greg Miller (greg.miller@hscni.net).
In Northern Ireland the number of melatonin items prescribed in primary care is significantly higher than any other region in the UK and continues to increase.
There is a lack of large-scale, high-quality evidence to demonstrate the cost-effectiveness, and long term efficacy and safety of melatonin for insomnia.
It is therefore critical that prescribing of melatonin initiated in primary care is reviewed to ensure that:
Any ongoing prescribing is clinically appropriate
Where prescribing is appropriate that a cost effective product is selected.
Community Pharmacies are asked to:
Assess melatonin stock levels in advance of potential prescribing change.
Provide direction and reassurance to patients whose prescription has been changed. In particular, address any concerns a patient may have in respect of any change to the product now prescribed or the evidence base for stopping melatonin.
ACTION
Ensure the information in the SPPG correspondence is brought to the attention of relevant members of the pharmacy team
Kind regards,
SENT ON BEHALF OF Gerard Greene Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
